- Home
- ZBAI vs BMRA Comparison
ZBAI vs BMRA Comparison
Compare ZBAI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAI
- BMRA
- Stock Information
- Founded
- ZBAI 2015
- BMRA 1971
- Country
- ZBAI United States
- BMRA United States
- Employees
- ZBAI N/A
- BMRA N/A
- Industry
- ZBAI Professional Services
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZBAI Consumer Discretionary
- BMRA Health Care
- Exchange
- ZBAI Nasdaq
- BMRA Nasdaq
- Market Cap
- ZBAI 6.5M
- BMRA 7.6M
- IPO Year
- ZBAI N/A
- BMRA N/A
- Fundamental
- Price
- ZBAI $6.68
- BMRA $2.91
- Analyst Decision
- ZBAI
- BMRA
- Analyst Count
- ZBAI 0
- BMRA 0
- Target Price
- ZBAI N/A
- BMRA N/A
- AVG Volume (30 Days)
- ZBAI 27.0K
- BMRA 2.4M
- Earning Date
- ZBAI 06-06-2025
- BMRA 10-14-2025
- Dividend Yield
- ZBAI N/A
- BMRA N/A
- EPS Growth
- ZBAI N/A
- BMRA N/A
- EPS
- ZBAI N/A
- BMRA N/A
- Revenue
- ZBAI $720,000.00
- BMRA $5,311,000.00
- Revenue This Year
- ZBAI N/A
- BMRA N/A
- Revenue Next Year
- ZBAI N/A
- BMRA N/A
- P/E Ratio
- ZBAI N/A
- BMRA N/A
- Revenue Growth
- ZBAI 44.00
- BMRA N/A
- 52 Week Low
- ZBAI $4.83
- BMRA $2.08
- 52 Week High
- ZBAI $45.00
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- ZBAI 55.05
- BMRA 42.73
- Support Level
- ZBAI $5.65
- BMRA $2.53
- Resistance Level
- ZBAI $6.43
- BMRA $3.22
- Average True Range (ATR)
- ZBAI 0.60
- BMRA 0.28
- MACD
- ZBAI 0.19
- BMRA -0.04
- Stochastic Oscillator
- ZBAI 73.83
- BMRA 35.51
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.